期刊文献+

子宫内膜癌中p16基因状态对端粒酶活性的影响 被引量:3

Effect of Different Type of p16 Gene Expression on The Telomerase Activity in Endometrial Carcinoma
下载PDF
导出
摘要 目的探讨子宫内膜癌中p16基因状态对端粒酶活性的影响。方法用PCR技术检测癌组织中p16基因的纯合性缺失及第一外显子异常甲基化,用原位杂交法检测端粒酶的表达。结果36例癌组织中,9例发生p16基因缺失,12例发生甲基化,未发现基因缺失与甲基化同时存在的病例;29例内膜癌端粒酶表达阳性,阳性率为80.56%。9例基因缺失标本中均有端粒酶的阳性表达,p16甲基化与否对端粒酶的表达影响无差异,但端粒酶阳性率在p16基因失活组明显高于p16基因未失活组。结论p16基因失活可以导致激活端粒酶端粒,p16基因失活的不同状态端粒酶激活的影响存在差异。 Objective To study the effect of MTS1/p16 gene deletion and 5'CpG island methylation on the expression of telomerase activity in endometrial carcinoma. Methods The p16 gene deletion and 5'CpG island methylation were determined by PCR technique, The telomerase catalytic protein subunit mRNA was assessed by in situ hibridization method. Results The p16 gene deletion and 5 'CpG island methylation rates in endometrial carcinoma were 25.00%(9/36)and 33. 33% (12/36) respectively. The telomerse expression rate was 80. 56% (29/36). In 36 cases of endometrial carcinoma, there was 9cases with p16 gene deletion and 12 cases with 5 'CpG island methylation, but no case with co-existence, 29cases has positive telomerse expressive. Each case with p16 gene deletion has positive telomerse expressive, whereas 5'CpG island methylation has no effect on telomerse expressive. The telomerse expression rate in p16 gene deletion group is higher than that in undeletion group, pl6 gene methylation had no effect on telomerse expression. Conclusion p16 gene deactivation would activate Telomerase expression, different type of p16 gene deactivation by p16gene deletion or 5'CpG island methylation has different effect on the Telomerase expression.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2006年第1期36-38,共3页 Cancer Research on Prevention and Treatment
关键词 子宫内膜癌 p16基因状态 端粒酶 Endometrial carcinoma MTS1/p16 gene Telomerase activity
  • 相关文献

参考文献9

二级参考文献41

  • 1傅松滨.多重肿瘤抑制基因MTS1/p16CDK4I与细胞周期调节[J].国外医学(遗传学分册),1996,19(1):7-13. 被引量:30
  • 2[1]Greider C W. Telomerase activity, cell proliferatio n, and cancer. Proc Natl Acad Sci USA, 1998, 95:90-92.
  • 3[2]Buys C H. Telomeres telomerase and cancer. N Engl J Med, 2000, 342:128 2-1283.
  • 4[3]Jong H S, Park Y I, Kim S, et al. Up-regulation of human telomerase c atalytic subunit during gastric carcinogenesis. Cancer, 1999, 86:559-565.
  • 5[4]He X S, Su Q, Chen Z C, et al. Expression deletion and mutation of p 1 6 gene in human gastric cancer. World J Gastroenterol, 2001,7:515-521.
  • 6[5]Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase sub units and correlation with telomerase activity in cervical cancer. Cancer Res, 1998, 58:1558-1561.
  • 7[6]Hiyama E, Yokozaki H, Kitadai Y, et al. In situ mRNA hybridization tec hnique for analysis of human telomerase RNA in gastric precancerous and cancerou s lesions. Jpn J Cancer Res, 1998, 89: 1187-1194.
  • 8[7]Kyo S, Kanaya T, Takakura M, et al. Human telomerase reverse transcrip tase as a critical determinant of telomerase activity in normal and malignant en dometrial tissues. Int J Cancer, 1999, 80:60-63.
  • 9[8]Bodnar A G, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into human normal cell. Science, 1998, 279:349-352.
  • 10[9]Kiyono T, Foster S A, Koop J I, et al. Both Rb/p16INK4a inactivation a nd telomerase activity are required to immortalize human epithelial cells. Natur e, 1998, 396:23-24.

共引文献21

同被引文献42

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部